在晚年患有晚期胰腺癌的老年患者中比较组合疗法与单化学疗法:来自单中心研究的见解
Elena Orlandi1, Chiara Citterio1, Rebecca Chinelli2
1Department of Oncology and Hematology, AUSL Piacenza Guglielmo da Saliceto Hospital, Piacenza, Italy.
Cancer control : journal of the Moffitt Cancer Center
|December 2, 2024
概括
对于75岁以上的胰腺癌老年患者,组合化疗 (多化学疗法) 与单药化疗 (单疗法) 相比,显著改善了整体生存率和无进展生存率. 由于并发症,需要仔细调整剂量.
科学领域:
- 在瘤学瘤学.
- 老年医学 老年医学
- 临床药理学 临床药理学
背景情况:
- 胰腺管道腺癌 (PDAC) 的发病率随着年龄的增长而上升,通常在不可手术的阶段被诊断出来.
- 治疗75岁以上患者的证据有限,第一线治疗指南不清楚.
- 老年患者经常有并发症,需要量身定制的治疗方法.
研究的目的:
- 在75岁以上的PDAC患者中,比较一线单化学疗法和多化学疗法之间的整体存活率 (OS).
- 评估不同一线化疗方案的无进展生存期 (PFS) 和安全概况.
- 确定影响老年PDAC患者治疗结果的因素.
主要方法:
- 在接受一线化疗的150名PDAC患者 (≥75岁) 的回顾性分析.
- 在72名单一疗法和78名多化学疗法患者之间的结局比较.
- 评估剂量修改 (大多数接受了降低剂量) 和并发症 (高血压,糖尿病常见).
主要成果:
- 多化学疗法显示,与单疗法相比,中位数的生存寿命 (8.2 vs 4.7 个月,P=0.0022) 和PFS (5.7 vs 2.8 个月,P=0.004) 显著更高.
- 多变量分析将低绩效状态,高CA19.9和单疗与更糟糕的生存状况联系起来.
- 多化学疗法与37%较低的一年死亡风险相关 (HR0.58,P=0.009).
结论:
- 在老年PDAC患者 (≥75岁) 中,多化学疗法可能比单疗法提供生存益处.
- 剂量调整对于管理该群体的并发病和多药性至关重要.
- 可行的多化学疗法方案可以平衡疗效和耐受性,改善PDAC的老年人的结果.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
